ALK7 and myostatin inhibitors and uses thereof

Details for Australian Patent Application No. 2005219441 (hide)

Owner Acceleron Pharma Inc.

Inventors Seehra, Jasbir; Knopf, John

Agent Shelston IP

Pub. Number AU-A-2005219441

PCT Pub. Number WO2005/084699

Priority 60/549,352 02.03.04 US

Filing date 2 March 2005

Wipo publication date 15 September 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084699 Priority application(s): WO2005/084699

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219443-Polymeric drug delivery system for hydrophobic drugs

2005219439-1-aminocyclohexane derivatives for the treatment of agitation and other behavioural disorders, especially those associated with alzheimer's disease